In Vitroandin VivoAntagonistic Regulation by Estradiol and Progesterone of the Rat Pituitary Domperidone Binding Sites: Correlation with Ovarian Steroid Regulation of the Dopaminergic Inhibition of Prolactin Secretionin Vitro*

Publisher Website
Google Scholar
Abstract
The influences of in vivo and in vitro estradiol (E2) and progesterone (P) treatments on the characteristics of [3H]domperidone binding to intact and ovariectomized (OVX) rat pituitary membranes were analyzed and compared to the modulation by these steroids of dopamine (DA) inhibition of PRL secretion in vitro from intact and OVX rat pituitaries. Using intact rat pituitaries, hig and low affinity binding sites for domperidone were detected; the dose-dependent DA inhibition curve of PRL [prolactin] secretion was biphasic (range, 10-13-10-10 M DA, IC50 [median inhibitory concentration dosage] = 6 .times. 10-12 M; range, 10-10-10-6 M DA, IC50 = 2.times. 10-8 M). Using OVX rat pituitaries, only the high affinity sites for domperidone were detected and the dose-dependent DA inhibition curve of PRL secretion was monophasic (range, 10-10-10-6 M DA, IC50 = 10-8 M). E2 and P did not modify the characteristics of the high affinity sites either after in vivo, treatment or when directly added to the in vitro binding assay. Using in vivo and in vitro tests, a modulation of the low affinity sites by E2 and P was demonstrated. When E2 is in excess and P levels are low or undetectable, these sites are not detectable, and P is able to restore there presence. A parallelism was established between this antagonistic E2 and P regulation and the modulation of DA inhibition of PRL secretion (range, 1013-1010 M DA). When intact rat pituitaries are perifused in the presence of 10-6 M E2, the biphasic dose-dependent inhibition curve of the control is changed into the monophasic curve of the OVX rat pituitaries. When OVX rat pituitaries are perifused in the presence of 10-6 M P, the monophasic curve of the control is changed into the biphasic curve of the intact rat pituitaries. The DA inhibition in the range 10-3-1010 M might resultfrom an interaction between DA and the low affinity site for domperidone. The biological regulation of PRL by DA at the pituitary level may be mediated by 2 ifferent DA sites, one being submitted to an antagonistic E2 and P regulation directly at the membrane level. The consequence of this regulation is that; E2 decrease the sensitivity of the cell to DA, P is necessary for a normal DA response of the lactotroph.